These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 25343854

  • 1. High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
    Ku BM, Jung HA, Sun JM, Ko YH, Jeong HS, Son YI, Baek CH, Park K, Ahn MJ.
    J Transl Med; 2014 Oct 25; 12():299. PubMed ID: 25343854
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of apocrine salivary duct carcinoma.
    Chiosea SI, Williams L, Griffith CC, Thompson LD, Weinreb I, Bauman JE, Luvison A, Roy S, Seethala RR, Nikiforova MN.
    Am J Surg Pathol; 2015 Jun 25; 39(6):744-52. PubMed ID: 25723113
    [Abstract] [Full Text] [Related]

  • 3. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
    Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A.
    Hum Pathol; 2019 Nov 25; 93():37-47. PubMed ID: 31437521
    [Abstract] [Full Text] [Related]

  • 4. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
    Gargano SM, Senarathne W, Feldman R, Florento E, Stafford P, Swensen J, Vranic S, Gatalica Z.
    Cancer Med; 2019 Dec 25; 8(17):7322-7329. PubMed ID: 31609094
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.
    Dalin MG, Desrichard A, Katabi N, Makarov V, Walsh LA, Lee KW, Wang Q, Armenia J, West L, Dogan S, Wang L, Ramaswami D, Ho AL, Ganly I, Solit DB, Berger MF, Schultz ND, Reis-Filho JS, Chan TA, Morris LG.
    Clin Cancer Res; 2016 Sep 15; 22(18):4623-33. PubMed ID: 27103403
    [Abstract] [Full Text] [Related]

  • 6. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
    Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, Ferris RL, Gooding WE.
    Cancer; 2016 Oct 15; 122(20):3136-3144. PubMed ID: 27379604
    [Abstract] [Full Text] [Related]

  • 7. Integrative genomic analysis of salivary duct carcinoma.
    Kim Y, Song S, Lee M, Swatloski T, Kang JH, Ko YH, Park WY, Jeong HS, Park K.
    Sci Rep; 2020 Sep 14; 10(1):14995. PubMed ID: 32929114
    [Abstract] [Full Text] [Related]

  • 8. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.
    Nardi V, Sadow PM, Juric D, Zhao D, Cosper AK, Bergethon K, Scialabba VL, Batten JM, Borger DR, Iafrate AJ, Heist RS, Lawrence DP, Flaherty KT, Bendell JC, Deschler D, Li Y, Wirth LJ, Dias-Santagata D.
    Clin Cancer Res; 2013 Jan 15; 19(2):480-90. PubMed ID: 23186780
    [Abstract] [Full Text] [Related]

  • 9. The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.
    Dogan S, Ng CKY, Xu B, Kumar R, Wang L, Edelweiss M, Scott SN, Zehir A, Drilon A, Morris LGT, Lee NY, Antonescu CR, Ho AL, Katabi N, Berger MF, Reis-Filho JS.
    Hum Pathol; 2019 Jun 15; 88():66-77. PubMed ID: 30946933
    [Abstract] [Full Text] [Related]

  • 10. PIK3CA mutations and PTEN loss in salivary duct carcinomas.
    Griffith CC, Seethala RR, Luvison A, Miller M, Chiosea SI.
    Am J Surg Pathol; 2013 Aug 15; 37(8):1201-7. PubMed ID: 23851329
    [Abstract] [Full Text] [Related]

  • 11. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma.
    Ryu HJ, Koh YW, Yoon SO.
    Hum Pathol; 2018 Nov 15; 81():18-25. PubMed ID: 29753009
    [Abstract] [Full Text] [Related]

  • 12. The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities.
    Alame M, Cornillot E, Cacheux V, Tosato G, Four M, De Oliveira L, Gofflot S, Delvenne P, Turtoi E, Cabello-Aguilar S, Nishiyama M, Turtoi A, Costes-Martineau V, Colinge J.
    Theranostics; 2020 Nov 15; 10(10):4383-4394. PubMed ID: 32292502
    [Abstract] [Full Text] [Related]

  • 13. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.
    Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK.
    Clin Cancer Res; 2014 Dec 15; 20(24):6570-81. PubMed ID: 25316813
    [Abstract] [Full Text] [Related]

  • 14. Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.
    Wang K, Russell JS, McDermott JD, Elvin JA, Khaira D, Johnson A, Jennings TA, Ali SM, Murray M, Marshall C, Oldham DS, Washburn D, Wong SJ, Chmielecki J, Yelensky R, Lipson D, Miller VA, Stephens PJ, Serracino HS, Ross JS, Bowles DW.
    Clin Cancer Res; 2016 Dec 15; 22(24):6061-6068. PubMed ID: 27334835
    [Abstract] [Full Text] [Related]

  • 15. Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.
    Schmitt NC, Kang H, Sharma A.
    Oral Oncol; 2017 Nov 15; 74():40-48. PubMed ID: 29103750
    [Abstract] [Full Text] [Related]

  • 16. Targeted molecular profiling of salivary duct carcinoma with rhabdoid features highlights parallels to other apocrine and discohesive neoplasms: which phenotype should drive classification?
    Rooper LM, Gagan J, Bishop JA.
    Head Neck Pathol; 2022 Dec 15; 16(4):1063-1072. PubMed ID: 35794510
    [Abstract] [Full Text] [Related]

  • 17. Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma.
    Qiu W, Tong GX, Turk AT, Close LG, Caruana SM, Su GH.
    Biomed Res Int; 2014 Dec 15; 2014():810487. PubMed ID: 24511546
    [Abstract] [Full Text] [Related]

  • 18. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.
    Williams MD, Roberts DB, Kies MS, Mao L, Weber RS, El-Naggar AK.
    Clin Cancer Res; 2010 Apr 15; 16(8):2266-74. PubMed ID: 20371674
    [Abstract] [Full Text] [Related]

  • 19. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
    Lubin D, Toorens E, Zhang PJ, Jaffer S, Baraban E, Bleiweiss IJ, Nayak A.
    Am J Surg Pathol; 2019 Jul 15; 43(7):1005-1013. PubMed ID: 31094929
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
    Masubuchi T, Tada Y, Maruya S, Osamura Y, Kamata SE, Miura K, Fushimi C, Takahashi H, Kawakita D, Kishimoto S, Nagao T.
    Int J Clin Oncol; 2015 Feb 15; 20(1):35-44. PubMed ID: 24553861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.